Oncogene - Table of Contents alert Volume 34 Issue 39

If you are unable to see the message below, click here to view.

Advertisement Validated ChIP antibodies you can TRUST — and try a sample!  Partnering with epigenetics experts in the BLUEPRINT epigenome consortium, Diagenode has developed completely validated epigenetics antibodies with: The highest specificity and sensitivity available Unparalleled MeDIP, ChIP, and ChIP-seq results Validated, so you have complete confidence in your results Learn more and try a sample today. TABLE OF CONTENTS Volume 34, Issue 39 (September 2015) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Junk DNA and the long non-coding RNA twist in cancer genetics H Ling, K Vincent, M Pichler, R Fodde, I Berindan-Neagoe, F J Slack and G A Calin Oncogene 2015 34: 5003-5011; advance online publication, January 26, 2015; 10.1038/onc.2014.456 Abstract | Full Text Original Articles Top FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer OPEN C Gong, K Fujino, L J Monteiro, A R Gomes, R Drost, H Davidson-Smith, S Takeda, U S Khoo, J Jonkers, D Sproul and E W-F Lam Oncogene 2015 34: 5012-5024; advance online publication, December 22, 2014; 10.1038/onc.2014.421 Abstract | Full Text LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression OPEN M Mura, T G Hopkins, T Michael, N Abd-Latip, J Weir, E Aboagye, F Mauri, C Jameson, J Sturge, H Gabra, M Bushell, A E Willis, E Curry and S P Blagden Oncogene 2015 34: 5025-5036; advance online publication, December 22, 2014; 10.1038/onc.2014.428 Abstract | Full Text Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4 Y Park, W Kim, J-M Lee, J Park, J K Cho, K Pang, J Lee, D Kim, S-W Park, K-M Yang and S-J Kim Oncogene 2015 34: 5037-5045; advance online publication, December 22, 2014; 10.1038/onc.2014.423 Abstract | Full Text A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription A-S Musahl, X Huang, S Rusakiewicz, E Ntini, A Marsico, G Kroemer, O Kepp and U A Ørom Oncogene 2015 34: 5046-5054; advance online publication, January 12, 2015; 10.1038/onc.2014.424 Abstract | Full Text SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma P Y Hernanda, K Chen, A M Das, K Sideras, W Wang, J Li, W Cao, S J A Bots, L L Kodach, R A de Man, J N M Ijzermans, H L A Janssen, A P Stubbs, D Sprengers, M J Bruno, H J Metselaar, T L M ten Hagen, J Kwekkeboom, M P Peppelenbosch and Q Pan Oncogene 2015 34: 5055-5068; advance online publication, December 22, 2014; 10.1038/onc.2014.425 Abstract | Full Text NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma S Zhao, L Kurenbekova, Y Gao, A Roos, C J Creighton, P Rao, J Hicks, T-K Man, C Lau, A M C Brown, S N Jones, A J Lazar, D Ingram, D Lev, L A Donehower and J T Yustein Oncogene 2015 34: 5069-5079; advance online publication, January 12, 2015; 10.1038/onc.2014.429 Abstract | Full Text Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma C Lecointre, L Desrues, J E Joubert, N Perzo, P-O Guichet, V Le Joncour, C Brulé, M Chabbert, R Leduc, L Prézeau, A Laquerrière, F Proust, P Gandolfo, F Morin and H Castel Oncogene 2015 34: 5080-5094; advance online publication, January 19, 2015; 10.1038/onc.2014.433 Abstract | Full Text Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM+ AFP+ hepatocellular carcinoma X Zhao, S Parpart, A Takai, S Roessler, A Budhu, Z Yu, M Blank, Y E Zhang, H-L Jia, Q-H Ye, L-X Qin, Z-Y Tang, S S Thorgeirsson and X W Wang Oncogene 2015 34: 5095-5104; advance online publication, January 19, 2015; 10.1038/onc.2014.438 Abstract | Full Text Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952. Explore the benefits of submitting your next research article: http://bit.ly/1vUuaXe Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.